The latest closing stock price for Kyverna Therapeutics as of January 21, 2025 is 3.34.
An investor who bought $1,000 worth of Kyverna Therapeutics stock at the IPO in 2024 would have $-889 today, roughly -1 times their original investment - a -88.87% compound annual growth rate over 1 years.
The all-time high Kyverna Therapeutics stock closing price was 30.10 on February 09, 2024.
The Kyverna Therapeutics 52-week high stock price is 35.06, which is 949.7% above the current share price.
The Kyverna Therapeutics 52-week low stock price is 3.22, which is 3.6% below the current share price.
The average Kyverna Therapeutics stock price for the last 52 weeks is 11.69.
An investor who bought $1,000 worth of Kyverna Therapeutics stock at the IPO in 2024 would have $-889 today, roughly -1 times their original investment - a -88.87% compound annual growth rate over 1 years.
The all-time high Kyverna Therapeutics stock closing price was 30.10 on February 09, 2024.
The Kyverna Therapeutics 52-week high stock price is 35.06, which is 949.7% above the current share price.
The Kyverna Therapeutics 52-week low stock price is 3.22, which is 3.6% below the current share price.
The average Kyverna Therapeutics stock price for the last 52 weeks is 11.69.